Showing results (591-600 of 689) with videos related to

Sort By:
Pageof 69
Nature Biotechnology|April 30, 2021
CRISPR prime editing with ribonucleoprotein complexes in zebrafish and primary human cellsKarl Petri, Weiting Zhang, Junyan Ma, et al.
Oncotarget|April 19, 2017
Camptothecin resistance is determined by the regulation of topoisomerase I degradation mediated by ubiquitin proteasome pathwayKoji Ando, Ankur K Shah, Vibhu Sachdev, et al.
Progress in Transplantation (Aliso Viejo, Calif.)|July 9, 2011
Identifying and addressing barriers to African American and non-African American families' discussions about preemptive living related kidney transplantationL Ebony Boulware, Felicia Hill-Briggs, Edward S Kraus, et al.
Human Gene Therapy|December 30, 2014
Fanconi anemia gene editing by the CRISPR/Cas9 systemMark J Osborn, Richard Gabriel, Beau R Webber, et al.
The Science of the Total Environment|December 23, 2019
Association between residential greenness and exposure to volatile organic compoundsRay Yeager, Daniel W Riggs, Natasha DeJarnett, et al.
Nucleic Acids Research|February 14, 2014
An improved predictive recognition model for Cys(2)-His(2) zinc finger proteinsAnkit Gupta, Ryan G Christensen, Heather A Bell, et al.
Plant Physiology|April 6, 2011
Targeted mutagenesis of duplicated genes in soybean with zinc-finger nucleasesShaun J Curtin, Feng Zhang, Jeffry D Sander, et al.
Nature Medicine|April 15, 2020
Therapeutic base editing of human hematopoietic stem cellsJing Zeng, Yuxuan Wu, Chunyan Ren, et al.
Molecular Therapy. Nucleic Acids|May 4, 2022
CRISPR-Cas9 treatment partially restores amyloid-β 42/40 in human fibroblasts with the Alzheimer's disease <i>PSEN</i> <i>1</i> M146L mutationEvangelos Konstantinidis, Agnieszka Molisak, Florian Perrin, et al.
Molecular Therapy. Nucleic Acids|June 3, 2018
CRISPR/Cas9 Mediated Disruption of the Swedish APP Allele as a Therapeutic Approach for Early-Onset Alzheimer's DiseaseBence György, Camilla Lööv, Mikołaj P Zaborowski, et al.
Pageof 69